Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial
1Department of Cardiology, Kayseri Education and Research Hospital, 38010, Kayseri, Turkey, drsarli@yahoo.com.
Insights
Elevated D-dimer levels in ST-elevated myocardial infarction (STEMI) patients predict no-reflow and adverse cardiovascular events after percutaneous coronary intervention (PCI). This finding aids in risk stratification for STEMI outcomes.
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Background:
- Preintervention thrombus burden impacts outcomes in coronary artery disease.
- The role of D-dimers in ST-elevated myocardial infarction (STEMI) during primary percutaneous coronary intervention (PCI) requires further elucidation.
Purpose of the Study:
- To investigate the predictive value of serum D-dimer levels for outcomes in STEMI patients undergoing primary PCI.
- To assess the association between D-dimer levels and postinterventional no-reflow and major adverse cardiovascular events (MACE).
Main Methods:
- A cohort of 266 STEMI patients within 12 hours of symptom onset were analyzed.
- Patients were stratified into no-reflow (TIMI grades 0-2) and TIMI 3 flow groups post-PCI.
- Multivariate logistic regression and ROC analyses were performed to evaluate D-dimer's predictive capacity.
Main Results:
- D-dimer levels were significantly higher in the no-reflow group compared to the TIMI 3 flow group (686 vs. 418 μg/ml, p < 0.001).
- Serum D-dimer independently predicted postinterventional no-reflow (OR: 1.005; p < 0.001) and in-hospital MACE (OR: 1.002; p = 0.029).
- Optimal D-dimer cut-off values were identified for predicting no-reflow (549 μg/ml) and MACE (544 μg/ml).
Conclusions:
- Serum D-dimer levels on admission are an independent predictor of no-reflow in STEMI patients.
- No-reflow is itself a predictor of adverse outcomes, highlighting D-dimer's prognostic significance in STEMI management.
Objective:
Preintervention thrombus burden in the infarct-related artery is an independent predictor of no-reflow and adverse outcomes in coronary artery disease. The role of D-dimers in the acute phase of ST-elevated myocardial infarction (STEMI) during primary percutaneous coronary intervention (PCI) has not been fully elucidated. We aimed to investigate the predictive value of serum D-dimer levels on the outcome of patients with STEMI.
Methods And Results:
A total of 266 consecutive patients presenting with STEMI within the first 12 h of symptom onset were included in this study. Patients were divided into two groups based on the postinterventional Thrombolysis In Myocardial Infarction (TIMI) flow grade score. Postinterventional TIMI grades of 0, 1, or 2 were defined as no-reflow (group 1) and angiographic success was defined as TIMI 3 flow (group 2). D-dimer levels were significantly higher in patients with postinterventional no-reflow than in patients with postinterventional TIMI grade 3 flow (686 ± 236 μg/ml-418 ± 164 μg/ml, p < 0.001). Multivariate logistic regression analysis showed that D-dimer level was an independent predictor of postinterventional no-reflow (OR: 1.005; 95 % CI: 1.003-1.007; p < 0.001) and in-hospital major adverse cardiovascular events (MACE; OR: 1.002; 95 % CI: 1.000-1.004; p = 0.029). Receiver operator characteristics analysis provided a cut-off value of 549 μg/ml for D-dimer for predicting no-reflow with an 83 % sensitivity and an 81 % specificity, and 544 μg/ml for predicting in-hospital MACE with a 69 % sensitivity and a 67 % specificity.
Conclusion:
In conclusion, D-dimer levels measured on admission may be an independent predictor of no-reflow, which is also a predictor of adverse outcomes in patients with STEMI.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

